BAX and ovarian carcinoma: BCL-2, BCL-XL, MCL-1 and BAX are determinants of apoptosis in response to chemotherapeutic agents, and are variably expressed in ovarian cancers (Jones et al, 1998; Chun and Lee, 2004).